Mark H. Lepper

4.9k total citations · 3 hit papers
104 papers, 3.7k citations indexed

About

Mark H. Lepper is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark H. Lepper has authored 104 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 18 papers in Infectious Diseases and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark H. Lepper's work include Pneumonia and Respiratory Infections (13 papers), Antibiotic Resistance in Bacteria (9 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Mark H. Lepper is often cited by papers focused on Pneumonia and Respiratory Infections (13 papers), Antibiotic Resistance in Bacteria (9 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Mark H. Lepper collaborates with scholars based in United States, Australia and Vietnam. Mark H. Lepper's co-authors include Oglesby Paul, Jeremiah Stamler, Richard B. Shekelle, Alan R. Dyer, Harlley E. McKean, Harry F. Dowling, William J. Raynor, Hee-Bok Park, David M. Berkson and Howard A. Lindberg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Mark H. Lepper

95 papers receiving 3.0k citations

Hit Papers

Diet, Serum Cholesterol, and Death from Coronary Hea... 1951 2026 1976 2001 1981 1963 1951 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark H. Lepper United States 28 727 670 594 462 438 104 3.7k
John Lindenbaum United States 39 278 0.4× 421 0.6× 256 0.4× 1.3k 2.7× 392 0.9× 85 6.8k
T. P. Whitehead United Kingdom 30 341 0.5× 496 0.7× 264 0.4× 362 0.8× 504 1.2× 113 3.6k
Eli A. Friedman United States 43 639 0.9× 944 1.4× 529 0.9× 1.3k 2.9× 410 0.9× 292 8.9k
E A Roberts Canada 19 299 0.4× 1.4k 2.0× 738 1.2× 1.4k 3.1× 563 1.3× 34 9.5k
Chris Bates United Kingdom 36 711 1.0× 328 0.5× 204 0.3× 342 0.7× 245 0.6× 119 4.5k
G. Neale United Kingdom 35 213 0.3× 665 1.0× 132 0.2× 880 1.9× 202 0.5× 136 4.1k
J Delaye France 18 2.0k 2.8× 433 0.6× 840 1.4× 883 1.9× 260 0.6× 67 4.7k
M. J. S. Langman United Kingdom 45 247 0.3× 802 1.2× 717 1.2× 3.0k 6.5× 486 1.1× 168 7.1k
Jaason Haapakoski Finland 20 885 1.2× 1.3k 1.9× 297 0.5× 812 1.8× 168 0.4× 47 4.2k
Hyman J. Zimmerman United States 50 192 0.3× 3.2k 4.8× 250 0.4× 1.1k 2.3× 719 1.6× 198 9.3k

Countries citing papers authored by Mark H. Lepper

Since Specialization
Citations

This map shows the geographic impact of Mark H. Lepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Lepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Lepper more than expected).

Fields of papers citing papers by Mark H. Lepper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Lepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Lepper. The network helps show where Mark H. Lepper may publish in the future.

Co-authorship network of co-authors of Mark H. Lepper

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Lepper. A scholar is included among the top collaborators of Mark H. Lepper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Lepper. Mark H. Lepper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dowling, Harry F., et al.. (2015). Bacteriologic Studies of the Sputum in Patients with Chronic Bronchitis and Bronchiectasis1, 2. American Review of Respiratory Disease.
2.
Dyer, Alan R., Kiang Liu, Jeremiah Stamler, et al.. (1988). Education, Smoking and Non-Cardiovascular Mortality: Findings in Three Chicago Epidemiological Studies. International Journal of Epidemiology. 17(2). 341–347. 11 indexed citations
3.
Dyer, Alan R., Jeremiah Stamler, Richard B. Shekelle, et al.. (1982). Relative weight and blood pressure in four Chicago epidemiologic studies. Journal of Chronic Diseases. 35(12). 897–908. 15 indexed citations
4.
Dyer, Alan R., Jeremiah Stamler, Richard B. Shekelle, et al.. (1982). Pulse pressure—II. Factors associated with follow-up values in three Chicago epidemiologic studies. Journal of Chronic Diseases. 35(4). 275–282. 16 indexed citations
5.
Dyer, Alan R., Jeremiah Stamler, Richard B. Shekelle, et al.. (1982). Pulse pressure—I. Level and associated factors in four Chicago epidemiologic studies. Journal of Chronic Diseases. 35(4). 259–273. 16 indexed citations
6.
Dyer, Alan R., Jeremiah Stamler, O Paul, et al.. (1977). Alcohol consumption, cardiovascular risk factors, and mortality in two Chicago epidemiologic studies.. Circulation. 56(6). 1067–1074. 249 indexed citations
7.
Carlsmith, J. Merrill, et al.. (1970). Experimental Analysis of the Factors Determining Obedience of Four-Year-Old Children to Adult Females. Child Development. 41(3). 601–601. 14 indexed citations
8.
Baltch, Aldona L., Mark H. Lepper, & V. T. Lolans. (1966). Influence of Corticosteroid Therapy on Serum Complement, Agglutinins, Free-Boundary Electrophoresis, Total Protein and Blood Counts in Dogs with Staphylococcal Bacteremia. The Journal of Immunology. 96(1). 149–158. 4 indexed citations
9.
Lepper, Mark H., et al.. (1966). IN VITRO COMPARISON OF FLUORESCENT ANTIBODY TECHNIQUE WITH CULTURE AND SLIDE AGGLUTINATION FOR THE DETECTION OF ENTEROPATHOGENIC ESCHERICHIA COLI. The American Journal of the Medical Sciences. 252(1). 75–77. 2 indexed citations
10.
Lepper, Mark H., et al.. (1965). Relationship of the Antigenic Structure of Sputum and Tracheobronchial Mucosa 1, 2. American Review of Respiratory Disease. 91(1). 59–63. 5 indexed citations
11.
Sobel, Solomon, et al.. (1962). ADVERSE REACTIONS TO TETRACYCLINE, PENICILLIN AND AN OLEANDOMYCIN-PENICILLIN MIXTURE USED IN THE LONG-TERM THERAPY OF CHRONIC PULMONARY DISEASE. The American Journal of the Medical Sciences. 243(3). 341–353. 6 indexed citations
12.
Winzler, Richard J., et al.. (1961). Turnover of plasma orosomucoid in man. Journal of Laboratory and Clinical Medicine. 57(1). 7–15. 26 indexed citations
13.
Lepper, Mark H.. (1961). The Use and Misuse of Antibiotics and Other Chemotherapeutic Agents. Medical Clinics of North America. 45(6). 1663–1676. 2 indexed citations
14.
Steblay, Raymond W. & Mark H. Lepper. (1961). Some immunologic properties of human and dog glomerular basement membrane. II. Nephritis produced in dogs by rabbit antihuman glomerular basement membrane sera.. PubMed. 87. 636–46. 18 indexed citations
15.
Lepper, Mark H., et al.. (1959). Use of amphotericin to eliminate Candida from the stools of Infants treated with tetracycline.. 1 indexed citations
16.
Lepper, Mark H.. (1959). Treatment of Pneumococcic Meningitis. A M A Archives of Internal Medicine. 104(2). 253–253. 17 indexed citations
17.
Jackson, George Gee, Mark H. Lepper, & Harry F. Dowling. (1954). Bacteriophage Typing of Staphylococci. III. Relationship to Antibiotic Sensitivity and Resistance.. Journal of Laboratory and Clinical Medicine. 44(1). 41–50. 11 indexed citations
18.
Neter, E., et al.. (1953). Round Table Discussion ANTIBIOTICS. PEDIATRICS. 11(3). 270–279. 3 indexed citations
19.
Bunn, Paul A., et al.. (1951). Absorption and Clinical Use of Penicillin Preparations Given in Large Oral Doses. Plastic & Reconstructive Surgery. 7(3). 260–261. 7 indexed citations
20.
Lepper, Mark H., et al.. (1951). Use of terramycin in some infectious diseases. The American Journal of Medicine. 10(2). 238–238. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026